EUVIMEDEUVIMED entdecken
Fallbericht

Primary esophageal small-cell neuroendocrine carcinoma managed with induction chemotherapy followed by definitive chemoradiotherapy in an elderly patient: A case report

Salma Ichou, Imane Hassnaoui, Amine Lachgar, Karima Nouni, Hanan ElKacemi, Tayeb Kebdani, Khalid Hassouni

MedPeer publisher · 2026

DOI: 10.70780/medpeer.000qgum ↗

Kurz gefasst

Fallbericht in der Zeitschrift MedPeer publisher, 2026. Verfasst von Salma Ichou und 6 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary small-cell neuroendocrine carcinoma of the esophagus is a rare and aggressive malignancy, accounting for less than 3% of esophageal cancers. Its biological behavior resembles that of small-cell lung cancer, with rapid growth, early lymphatic spread, and a poor prognosis. No standardized treatment exists, and management in elderly patients is particularly challenging given the balance between disease control and treatment-related toxicity. Case Presentation: An 85-year-old man with a history of hypertension and chronic tobacco exposure presented with progressive dysphagia, vomiting, and a 9-kg weight loss over one month. Endoscopy revealed a circumferential ulcerated and budding lesion of the thoracic esophagus. Histopathology and immunohistochemistry confirmed primary small-cell neuroendocrine carcinoma (synaptophysin- and CD56-positive, Ki-67 approaching 100%). Staging with computed tomography and ¹⁸F-FDG PET/CT showed locally advanced, nonmetastatic disease (cT3N1M0, clinical stage III). Given the patient's preserved performance status despite advanced age, he received three cycles of induction carboplatin–etoposide chemotherapy followed by definitive concurrent chemoradiotherapy (50.4 Gy in 28 fractions with concurrent platinum–etoposide). Treatment was overall well tolerated, although the patient required a two-week hospitalization for management of dysphagia to liquids and odynophagia. At one year of follow-up, disease control remained favorable.

Conclusion

This case illustrates that individualized, multimodal treatment combining induction chemotherapy and definitive chemoradiotherapy can be safely delivered and achieve favorable outcomes in a very elderly patient with locally advanced esophageal small-cell neuroendocrine carcinoma, provided that performance status and patient preferences are carefully considered.

Zitieren

APA

Ichou, S., Hassnaoui, I., Lachgar, A., Nouni, K., ElKacemi, H., Kebdani, T., & Hassouni, K. (2026). Primary esophageal small-cell neuroendocrine carcinoma managed with induction chemotherapy followed by definitive chemoradiotherapy in an elderly patient: A case report. MedPeer publisher. https://doi.org/10.70780/medpeer.000qgum

Vancouver

Ichou S, Hassnaoui I, Lachgar A, Nouni K, ElKacemi H, Kebdani T, et al. Primary esophageal small-cell neuroendocrine carcinoma managed with induction chemotherapy followed by definitive chemoradiotherapy in an elderly patient: A case report. MedPeer publisher. 2026. doi:10.70780/medpeer.000qgum

BibTeX
@article{Ichou2026,
  author = {Ichou, Salma and Hassnaoui, Imane and Lachgar, Amine and Nouni, Karima and ElKacemi, Hanan and Kebdani, Tayeb and Hassouni, Khalid},
  title = {Primary esophageal small-cell neuroendocrine carcinoma managed with induction chemotherapy followed by definitive chemoradiotherapy in an elderly patient: A case report},
  journal = {MedPeer publisher},
  year = {2026},
  doi = {10.70780/medpeer.000qgum}
}
Kostenlos starten →